205 related articles for article (PubMed ID: 28973823)
1. Augmented O-GlcNAcylation of AMP-activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line.
Ishimura E; Nakagawa T; Moriwaki K; Hirano S; Matsumori Y; Asahi M
Cancer Sci; 2017 Dec; 108(12):2373-2382. PubMed ID: 28973823
[TBL] [Abstract][Full Text] [Related]
2. Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells.
Jin L; Yuan F; Dai G; Yao Q; Xiang H; Wang L; Xue B; Shan Y; Liu X
Cell Mol Biol Lett; 2020; 25():17. PubMed ID: 32174982
[TBL] [Abstract][Full Text] [Related]
3. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
[TBL] [Abstract][Full Text] [Related]
5. Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle.
Murata K; Morino K; Ida S; Ohashi N; Lemecha M; Park SY; Ishikado A; Kume S; Choi CS; Sekine O; Ugi S; Maegawa H
Biochem Biophys Res Commun; 2018 Jan; 495(2):2098-2104. PubMed ID: 29253568
[TBL] [Abstract][Full Text] [Related]
6. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
7. Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells.
Inoue Y; Moriwaki K; Ueda Y; Takeuchi T; Higuchi K; Asahi M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1681-1687. PubMed ID: 29196265
[TBL] [Abstract][Full Text] [Related]
8. Cross regulation between mTOR signaling and O-GlcNAcylation.
Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
[TBL] [Abstract][Full Text] [Related]
9. Augmented TME
Moriwaki K; Asahi M
Mol Cancer Res; 2017 Sep; 15(9):1287-1298. PubMed ID: 28536142
[No Abstract] [Full Text] [Related]
10. O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway.
Ferrer CM; Lu TY; Bacigalupa ZA; Katsetos CD; Sinclair DA; Reginato MJ
Oncogene; 2017 Jan; 36(4):559-569. PubMed ID: 27345396
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
[TBL] [Abstract][Full Text] [Related]
13. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
14. AMPK regulates histone H2B O-GlcNAcylation.
Xu Q; Yang C; Du Y; Chen Y; Liu H; Deng M; Zhang H; Zhang L; Liu T; Liu Q; Wang L; Lou Z; Pei H
Nucleic Acids Res; 2014 May; 42(9):5594-604. PubMed ID: 24692660
[TBL] [Abstract][Full Text] [Related]
15. Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells.
Chen MB; Zhang Y; Wei MX; Shen W; Wu XY; Yao C; Lu PH
Cell Signal; 2013 Oct; 25(10):1993-2002. PubMed ID: 23712032
[TBL] [Abstract][Full Text] [Related]
16. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
Harosh-Davidovich SB; Khalaila I
Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
[TBL] [Abstract][Full Text] [Related]
18. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
19. GFAT1 phosphorylation by AMPK promotes VEGF-induced angiogenesis.
Zibrova D; Vandermoere F; Göransson O; Peggie M; Mariño KV; Knierim A; Spengler K; Weigert C; Viollet B; Morrice NA; Sakamoto K; Heller R
Biochem J; 2017 Mar; 474(6):983-1001. PubMed ID: 28008135
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
